Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

The prevention, diagnosis, and management of infectious disease in transplantation are
major contributors to improved outcomes in organ transplantation. The risk of serious …

Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

Short-term patient and graft outcomes continue to improve after kidney and liver
transplantation, with 1-year survival rates over 80%; however, improving longer-term …

Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …

Background Everolimus permits reduced calcineurin inhibitor (CNI) exposure, but the
efficacy and safety outcomes of this treatment after kidney transplant require confirmation …

Cytomegalovirus (CMV) is a ubiquitousherpes virus that infects the majority of humans (1).
The seroprevalence rates of CMV ranges from 30–97%(2, 3). Primary infection manifests as …

Cytomegalovirus infection is a frequent complication after transplantation. This infection
occurs due to transmission from the transplanted organ, due to reactivation of latent …

Cytomegalovirus (CMV) is the most common infection after organ transplantation and has a
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …

This review focuses on recent advances in the field of cytomegalovirus (CMV). The 2 main
strategies for CMV prevention are prophylaxis and preemptive therapy. Prophylaxis …